Dr. Roxana Rose Daneshjou, MD

Dr. Daneshjou practices at Stanford Hospital at 300 Pasteur Drive in Stanford, California, part of Stanford University.

Dr. Daneshjou's NPI, 1780048991, was assigned on April 13, 2016. Dr. Daneshjou graduated from Stanford University School Of Medicine in 2016. Dr. Daneshjou holds California license A150351.

Dr. Daneshjou's primary practice is Stanford Hospital at 300 Pasteur Drive, at 300 Pasteur Drive, Stanford, CA 94305 in Santa Clara County. The practice phone is (650) 723-4000.

Dr. Daneshjou's primary practice is Stanford Hospital at 300 Pasteur Drive in Stanford, California, part of Stanford University. The medical group on file is Stanford Health Care. Dmand AI also links Dr. Daneshjou to 1 more hospital and 1 medical group, each named with a free account. Dr. Daneshjou's employer is on file too: a hospital.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Daneshjou practices, 2 sites in all. Vendor and product names are available with a free account.

Dermatology is Dr. Daneshjou's primary specialty in the NPI Registry, under taxonomy code 207N00000X. Dr. Daneshjou is board certified in dermatology by the American Board of Dermatology. Dr. Daneshjou is licensed in California.

Dmand AI lists benign or precancerous skin growths, contact dermatitis, itchy rashes, psoriasis, scalp rash, skin cyst and skin discoloration among the conditions Dr. Daneshjou treats.

CMS data shows 276 Medicare services from Dr. Daneshjou across 5 procedure codes in 2024, for 75 Medicare patients. Medicare paid $7,369 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 75 Medicare patients who saw Dr. Daneshjou in 2024. The largest group is 65 to 74, with 34 patients. 75% of them have high cholesterol, and 67% have high blood pressure. 19% are also on Medicaid. Their average risk score is 1.24, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Daneshjou's median patient age at 55, with 65% women.

In 2024, Dr. Daneshjou wrote 116 Medicare Part D claims for 28 patients. 96% of them were for generic drugs. CMS names the drug for 42 of them, across 3 drugs with 11 or more claims each, at $1,046 in total drug cost. In 2023, CMS named 117 claims across 6 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 89 out of 100 for Dr. Daneshjou for performance year 2024, reported as part of a group. Dr. Daneshjou accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 48 procedures of removal of skin lesions by Dr. Daneshjou, more than 71% of the clinicians it reports for that procedure.

Dmand AI links 75 papers to Dr. Daneshjou, published from 2011 to 2025. 2024 was the busiest year, with 15. The most frequent topics are Artificial Intelligence, Dermatology and Algorithms. Dr. Daneshjou has published most often in J Invest Dermatol. Dr. Daneshjou's most frequent co-authors are Russ B. Altman, MD, Veronica M. Rotemberg and Justin Meng Ko, MD.

CMS Open Payments shows 6 general payments to Dr. Daneshjou from 4 drug and device companies from 2018 to 2024. Honoraria make up the largest share, 55% of the total. Pfizer Inc. paid the most, $9,250.

Dr. Daneshjou graduated from Stanford University School Of Medicine in 2016.

Dr. Daneshjou is in network with 7 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. HMO plans come from the most carriers, 4. Check the plan with the practice before a visit.